Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis

E. M. Pich, M. Lorang, M. Yeganeh, F. R. De Fonseca, Jacob Raber, G. F. Koob, F. Weiss

Research output: Contribution to journalArticle

470 Citations (Scopus)

Abstract

Previous research has suggested a role for corticotropin-releasing factor (CRF) in the anxiogenic effects of stressful stimuli and ethanol withdrawal. This hypothesis was explored in a series of experiments using intracranial microdialysis to monitor CRF-like immunoreactivity (CRF-IR) in the extracellular compartment of the rat amygdala. The synaptic origin of CRF-IR release in the amygdala was determined in vitro by assessing the Ca2+ dependency of 4-aminopyridine stimulated CRF-IR release from tissue preparations of rat amygdala. In vivo experiments were performed in awake rats after the placement of microdialysis probes in the amygdala. In the first experiment, transient restraint stress (20 min) produced an increase of CRF-IR release (basal levels, 1.19 ± 0.15 fmol/50 μl; stress levels, 4.54 ± 1.33 fmol/50 μl; p <0.05) that returned to basal values within 1 hr. When 4-aminopyridine (5 mM) was added to the perfusion medium, it consistently increased CRF-IR release (4.83 ± 0.92 fmol/50 μl, p <0.05). In the second experiment, CRF-IR release was measured during ethanol withdrawal in rats previously maintained for 2-3 weeks on a liquid diet containing ethanol (8.5%). Basal CRF-IR levels were 2.10 ± 0.43 fmol/50 μl in ethanol exposed rats and 1.30 ± 0.19 fmol/50 μl in control rats. During withdrawal, a progressive increase of CRF-IR levels over time was observed, reaching peak values at 10-12 hr after the onset of withdrawal (10.65 ± 0.49 fmol/50 μl vs 1.15 ± 0.30 fmol/50 μl of control rats, p <0.01). Since the peak of CRF-IR release corresponded to the time of appearance of anxiogenic behavioral effects in rats, the present data lend further support to the hypothesis that the CRF-IR system in the amygdala participates in the mediation of the emotional component of the response to exogenous or endogenous stressful stimuli.

Original languageEnglish (US)
Pages (from-to)5439-5447
Number of pages9
JournalJournal of Neuroscience
Volume15
Issue number8
StatePublished - 1995
Externally publishedYes

Fingerprint

Corticotropin-Releasing Hormone
Microdialysis
Amygdala
Ethanol
4-Aminopyridine
Perfusion
Diet

Keywords

  • 4- aminopyridine
  • central amygdaloid nucleus
  • corticotropin-releasing factor
  • ethanol withdrawal
  • intracranial microdialysis
  • rat
  • stress

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. / Pich, E. M.; Lorang, M.; Yeganeh, M.; De Fonseca, F. R.; Raber, Jacob; Koob, G. F.; Weiss, F.

In: Journal of Neuroscience, Vol. 15, No. 8, 1995, p. 5439-5447.

Research output: Contribution to journalArticle

@article{adfd927b8ffe405195fce099d82bfc78,
title = "Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis",
abstract = "Previous research has suggested a role for corticotropin-releasing factor (CRF) in the anxiogenic effects of stressful stimuli and ethanol withdrawal. This hypothesis was explored in a series of experiments using intracranial microdialysis to monitor CRF-like immunoreactivity (CRF-IR) in the extracellular compartment of the rat amygdala. The synaptic origin of CRF-IR release in the amygdala was determined in vitro by assessing the Ca2+ dependency of 4-aminopyridine stimulated CRF-IR release from tissue preparations of rat amygdala. In vivo experiments were performed in awake rats after the placement of microdialysis probes in the amygdala. In the first experiment, transient restraint stress (20 min) produced an increase of CRF-IR release (basal levels, 1.19 ± 0.15 fmol/50 μl; stress levels, 4.54 ± 1.33 fmol/50 μl; p <0.05) that returned to basal values within 1 hr. When 4-aminopyridine (5 mM) was added to the perfusion medium, it consistently increased CRF-IR release (4.83 ± 0.92 fmol/50 μl, p <0.05). In the second experiment, CRF-IR release was measured during ethanol withdrawal in rats previously maintained for 2-3 weeks on a liquid diet containing ethanol (8.5{\%}). Basal CRF-IR levels were 2.10 ± 0.43 fmol/50 μl in ethanol exposed rats and 1.30 ± 0.19 fmol/50 μl in control rats. During withdrawal, a progressive increase of CRF-IR levels over time was observed, reaching peak values at 10-12 hr after the onset of withdrawal (10.65 ± 0.49 fmol/50 μl vs 1.15 ± 0.30 fmol/50 μl of control rats, p <0.01). Since the peak of CRF-IR release corresponded to the time of appearance of anxiogenic behavioral effects in rats, the present data lend further support to the hypothesis that the CRF-IR system in the amygdala participates in the mediation of the emotional component of the response to exogenous or endogenous stressful stimuli.",
keywords = "4- aminopyridine, central amygdaloid nucleus, corticotropin-releasing factor, ethanol withdrawal, intracranial microdialysis, rat, stress",
author = "Pich, {E. M.} and M. Lorang and M. Yeganeh and {De Fonseca}, {F. R.} and Jacob Raber and Koob, {G. F.} and F. Weiss",
year = "1995",
language = "English (US)",
volume = "15",
pages = "5439--5447",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "8",

}

TY - JOUR

T1 - Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis

AU - Pich, E. M.

AU - Lorang, M.

AU - Yeganeh, M.

AU - De Fonseca, F. R.

AU - Raber, Jacob

AU - Koob, G. F.

AU - Weiss, F.

PY - 1995

Y1 - 1995

N2 - Previous research has suggested a role for corticotropin-releasing factor (CRF) in the anxiogenic effects of stressful stimuli and ethanol withdrawal. This hypothesis was explored in a series of experiments using intracranial microdialysis to monitor CRF-like immunoreactivity (CRF-IR) in the extracellular compartment of the rat amygdala. The synaptic origin of CRF-IR release in the amygdala was determined in vitro by assessing the Ca2+ dependency of 4-aminopyridine stimulated CRF-IR release from tissue preparations of rat amygdala. In vivo experiments were performed in awake rats after the placement of microdialysis probes in the amygdala. In the first experiment, transient restraint stress (20 min) produced an increase of CRF-IR release (basal levels, 1.19 ± 0.15 fmol/50 μl; stress levels, 4.54 ± 1.33 fmol/50 μl; p <0.05) that returned to basal values within 1 hr. When 4-aminopyridine (5 mM) was added to the perfusion medium, it consistently increased CRF-IR release (4.83 ± 0.92 fmol/50 μl, p <0.05). In the second experiment, CRF-IR release was measured during ethanol withdrawal in rats previously maintained for 2-3 weeks on a liquid diet containing ethanol (8.5%). Basal CRF-IR levels were 2.10 ± 0.43 fmol/50 μl in ethanol exposed rats and 1.30 ± 0.19 fmol/50 μl in control rats. During withdrawal, a progressive increase of CRF-IR levels over time was observed, reaching peak values at 10-12 hr after the onset of withdrawal (10.65 ± 0.49 fmol/50 μl vs 1.15 ± 0.30 fmol/50 μl of control rats, p <0.01). Since the peak of CRF-IR release corresponded to the time of appearance of anxiogenic behavioral effects in rats, the present data lend further support to the hypothesis that the CRF-IR system in the amygdala participates in the mediation of the emotional component of the response to exogenous or endogenous stressful stimuli.

AB - Previous research has suggested a role for corticotropin-releasing factor (CRF) in the anxiogenic effects of stressful stimuli and ethanol withdrawal. This hypothesis was explored in a series of experiments using intracranial microdialysis to monitor CRF-like immunoreactivity (CRF-IR) in the extracellular compartment of the rat amygdala. The synaptic origin of CRF-IR release in the amygdala was determined in vitro by assessing the Ca2+ dependency of 4-aminopyridine stimulated CRF-IR release from tissue preparations of rat amygdala. In vivo experiments were performed in awake rats after the placement of microdialysis probes in the amygdala. In the first experiment, transient restraint stress (20 min) produced an increase of CRF-IR release (basal levels, 1.19 ± 0.15 fmol/50 μl; stress levels, 4.54 ± 1.33 fmol/50 μl; p <0.05) that returned to basal values within 1 hr. When 4-aminopyridine (5 mM) was added to the perfusion medium, it consistently increased CRF-IR release (4.83 ± 0.92 fmol/50 μl, p <0.05). In the second experiment, CRF-IR release was measured during ethanol withdrawal in rats previously maintained for 2-3 weeks on a liquid diet containing ethanol (8.5%). Basal CRF-IR levels were 2.10 ± 0.43 fmol/50 μl in ethanol exposed rats and 1.30 ± 0.19 fmol/50 μl in control rats. During withdrawal, a progressive increase of CRF-IR levels over time was observed, reaching peak values at 10-12 hr after the onset of withdrawal (10.65 ± 0.49 fmol/50 μl vs 1.15 ± 0.30 fmol/50 μl of control rats, p <0.01). Since the peak of CRF-IR release corresponded to the time of appearance of anxiogenic behavioral effects in rats, the present data lend further support to the hypothesis that the CRF-IR system in the amygdala participates in the mediation of the emotional component of the response to exogenous or endogenous stressful stimuli.

KW - 4- aminopyridine

KW - central amygdaloid nucleus

KW - corticotropin-releasing factor

KW - ethanol withdrawal

KW - intracranial microdialysis

KW - rat

KW - stress

UR - http://www.scopus.com/inward/record.url?scp=0029117641&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029117641&partnerID=8YFLogxK

M3 - Article

VL - 15

SP - 5439

EP - 5447

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 8

ER -